Sanket Koul

West Asia conflict dents India's medical tourism, hospital inflow falls

Indian hospital chains report up to 30% drop in overseas patient inflow and revenue hit as the West Asia conflict disrupts medical travel and slows arrivals from key markets

India's indoor amusement market hits ₹15,000 cr, consumer spend rises 40%

India's indoor amusement industry has reached ₹15,000 crore as consumer spending rises, though high GST and regulatory gaps could affect expansion, says Anarock-IAAPI report

CDSCO asks drugmakers to stop GLP-1 obesity awareness ad campaigns

Drug regulator warns pharma companies that obesity awareness drives linked to GLP-1 drugs could amount to misleading promotion of prescription medicines

Centre proposes doing away with double testing of blood plasma products

Union Health Ministry moves to remove repeated HIV, Hepatitis tests on pooled plasma to align with global norms and ease compliance while maintaining patient safety

Centre plans national assessment of district hospitals for emergency care

The Centre will conduct a nationwide assessment of district hospitals to identify gaps in emergency and trauma care infrastructure and strengthen facilities in line with IPHS norms

Centre plans major push to train allied health professionals, caregivers

Addressing the concluding session of the webinar, Dr VK Paul, member (health) at government think tank NITI Aayog said that the strategic way forward includes strengthening existing institutions

Bhagwati Products leases 430,000 sq ft in Oppo's Noida manufacturing plant

Bhagwati Products has leased 430,000 sq ft in Oppo's Noida plant to expand smartphone output, marking another major industrial space deal amid strong demand in NCR's manufacturing hubs

Semaglutide generics likely to widen access but raise dropout risks

Experts add that while the introduction of branded generics will trigger an acceleration in volumes for GLP-1 agonists, the value growth may moderate due to price erosion

Indian pharma market grows 11% in Feb as Mounjaro tops drug sales

The Indian pharmaceutical market posted 11% growth in February 2026, driven by strong therapy performance, while Mounjaro remained India's highest-selling drug by value for a fifth month

Metlife GCC leases 75,000 sq ft in Noida's Oxygen Business Park

Metlife's global capacity centre has leased 75,000 sq ft at Embassy's Oxygen Business Park in Noida, adding to strong Grade-A office demand amid rising GCC activity and tech sector expansion

Embassy REIT raises ₹1,400 cr via 10-year NCD to boost long-term capital

Embassy REIT has raised ₹1,400 crore through a fully subscribed 10-year NCD issue, expanding its institutional investor base as the trust continues to secure long-duration capital

American business schools rewrite syllabus as Indian enrolments fall

Joint degrees and credit-sharing emerge as response to visa curbs and a 45% drop

Centre aiming to quadruple intake of foreign students in India by 2030

At least 2-3 more foreign universities to open campuses in India this year

Drugmakers may review shipment schedules to West Asia if conflict drags on

Indian drugmakers are reviewing shipment schedules and inventories for West Asia as escalating tensions threaten sea and air routes, raising freight costs and risking supply delays

Gaurs Group to invest ₹250 cr for precast manufacturing plant in Noida

Gaurs Group will invest Rs 250 crore to build a precast and modular construction facility in Noida after signing an MoU with Elematic India, aiming to boost efficiency and project timelines

Realty major TARC eyes phased launches in Delhi, Gurugram markets in FY27

TARC will prioritise Delhi and Gurugram in FY27 with phased launches across existing luxury projects, backed by strong demand momentum and projected cash-flow visibility over four years

Novo Nordisk, Abbott tie up to launch second Ozempic brand in India

Abbott will commercialise Extensior, a second semaglutide brand of Ozempic in India, as part of Novo Nordisk's strategy to expand access amid rising demand and looming patent expiry

NBCC inks MoUs with DDA for ₹775 crore redevelopment of staff colonies

NBCC has signed two MoUs with DDA for redeveloping staff colonies at Old Rajinder Nagar and Safdarjung Development Area, securing Rs 775 crore in projects under a self-sustainable model

CDSCO allows immediate lab testing of drugs to speed up approvals

CDSCO will permit drugmakers to begin testing samples as soon as applications are filed, shifting detailed scrutiny to later stages to shorten approval timelines and ease compliance

India may retain $113 bn forex as foreign universities set up campuses

A Knight Frank-Deloitte report says foreign universities establishing campuses in India could help retain $113 billion in foreign currency by 2040, easing large outflows for overseas education